BNF for Children 2016-2017
What's BNF for Children 2016-2017 APK?
BNF for Children 2016-2017 is a app for Android, It's developed by MedHand Mobile Libraries author.
First released on google play in 7 years ago and latest version released in 7 years ago.
This app has 0 download times on Google play
This product is an app in Medical category. More infomartion of BNF for Children 2016-2017 on google play
This Medical Association and Royal Pharmaceutical Society of Great Britain app-book for BNFCis developed by Medhand Mobile Libraries. Improve your performance with relevant, valid material which is
accessed quickly and with minimal effort in the palm of your hand using Medhands patented technology.
Functions include:
• A powerful search
• Bookmarks, History and Highlighting
• Complete set of medical calculators; Body Mass Index, Peak Expiratory Flows, Dehydration Correction Calculator and more
• Notes and picture notes
The BNF for Children (BNFC) 2016-2017 provides essential practical information to all healthcare professionals involved in the prescribing, dispensing, monitoring and administration of medicines to children.
Recommendations have been constructed on the basis of authoritative sources, emerging evidence and best practice guidelines. The content has been carefully validated by a network of paediatric experts and the process is overseen by a paediatric formulary committee.
The BNF for Children 2016-2017 has been revised and revalidated to reflect changes in product availability, emerging safety concerns and shifts in clinical practice.
Significant content updates include:
• New safety information about the risk of abnormal pregnancy outcomes with sodium valproate and valproic acid
• Updated guidance for conditions including asthma and obesity
• Updated pregnancy-prevention advice for patients taking mycophenolate mofetil
• New drug monographs including cholic acid
• New indications for adalimumab including chronic plaque psoriasis
• New safety information about the risk of osteonecrosis of the external auditory canal with bisphosphonates
• Guidance on suspected or confirmed drug allergies
• Evidence grading of BNF recommendations.
Unique benefits
• Shares the structure of the British National Formulary (BNF) and is designed to be used in paediatric and general practice settings
• Includes information on unlicensed use of medicines and provides details of unlicensed medicines that can be imported, manufactured by ‘special order' or prepared extemporaneously
• Covers the drug treatment of rare childhood conditions, provides guidance on specialist paediatric interventions and includes details of those medicines that are used in children in a different way to adults
International relevance
BNF and BNFC are the gold standard of drug information in English-speaking countries. They are used for constructing national formularies in other countries and to support regulatory work. They provide essential information when treating patients who have been prescribed medicines in the UK. Unlike many other local alternatives, both resources are completely independent from pharmaceutical industry influence with guidance that is based on best practice and real life evidence.
Published jointly by the British Medical Association, Royal Pharmaceutical Society, the Royal College of Paediatrics and Child Health, and the Neonatal and Paediatric Pharmacists Group.
________________________________________
MedHand Mobile Libraries offers a SUBSCRIPTION FREE application without edition upgrade. Offering most trusted and well recognized medical guidelines provided by excellent publishers like Pharmaceutical Press, Oxford University Press, McGraw-Hill, Elsevier, Wiley and more.
Functions include:
• A powerful search
• Bookmarks, History and Highlighting
• Complete set of medical calculators; Body Mass Index, Peak Expiratory Flows, Dehydration Correction Calculator and more
• Notes and picture notes
The BNF for Children (BNFC) 2016-2017 provides essential practical information to all healthcare professionals involved in the prescribing, dispensing, monitoring and administration of medicines to children.
Recommendations have been constructed on the basis of authoritative sources, emerging evidence and best practice guidelines. The content has been carefully validated by a network of paediatric experts and the process is overseen by a paediatric formulary committee.
The BNF for Children 2016-2017 has been revised and revalidated to reflect changes in product availability, emerging safety concerns and shifts in clinical practice.
Significant content updates include:
• New safety information about the risk of abnormal pregnancy outcomes with sodium valproate and valproic acid
• Updated guidance for conditions including asthma and obesity
• Updated pregnancy-prevention advice for patients taking mycophenolate mofetil
• New drug monographs including cholic acid
• New indications for adalimumab including chronic plaque psoriasis
• New safety information about the risk of osteonecrosis of the external auditory canal with bisphosphonates
• Guidance on suspected or confirmed drug allergies
• Evidence grading of BNF recommendations.
Unique benefits
• Shares the structure of the British National Formulary (BNF) and is designed to be used in paediatric and general practice settings
• Includes information on unlicensed use of medicines and provides details of unlicensed medicines that can be imported, manufactured by ‘special order' or prepared extemporaneously
• Covers the drug treatment of rare childhood conditions, provides guidance on specialist paediatric interventions and includes details of those medicines that are used in children in a different way to adults
International relevance
BNF and BNFC are the gold standard of drug information in English-speaking countries. They are used for constructing national formularies in other countries and to support regulatory work. They provide essential information when treating patients who have been prescribed medicines in the UK. Unlike many other local alternatives, both resources are completely independent from pharmaceutical industry influence with guidance that is based on best practice and real life evidence.
Published jointly by the British Medical Association, Royal Pharmaceutical Society, the Royal College of Paediatrics and Child Health, and the Neonatal and Paediatric Pharmacists Group.
________________________________________
MedHand Mobile Libraries offers a SUBSCRIPTION FREE application without edition upgrade. Offering most trusted and well recognized medical guidelines provided by excellent publishers like Pharmaceutical Press, Oxford University Press, McGraw-Hill, Elsevier, Wiley and more.
